Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Small Molecular Inhibitors for the Treatment of Rheumatoid Arthritis: Progress so Far

Author(s): Vadiraj D. Kurdekar and Hemant R. Jadhav

Volume 15, Issue 2, 2015

Page: [123 - 144] Pages: 22

DOI: 10.2174/1389557515666150101101850

Price: $65

Abstract

Rheumatoid Arthritis (RA) is an autoimmune disease characterized by persistent inflammation and joint damage. The main aim of RA treatment is to control the disease progress. Despite the success of biologicals like Adalimumab, Atlizumab, infliximab, etc. in treatment of RA, the high cost and associated immunological adverse effects have triggered discovery of small molecules targeting RA. This review describes the last 15 years of small molecular drug discovery in RA, focused mainly on preclinical and clinical studies.

Keywords: Janus kinase, peptidyl arginine deiminase, phosphoinositide 3-kinase, rheumatoid arthritis, TNFα-converting enzyme, Tyrosine kinase.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy